Pages that link to "Q26852366"

The following pages link to Challenges to targeting epidermal growth factor receptor in glioblastoma: escape mechanisms and combinatorial treatment strategies (Q26852366):

Displaying 22 items.

• Bi-specific molecule against EGFR and death receptors simultaneously targets proliferation and death pathways in tumors (Q33753135) (← links)
• In vitro antineoplastic effects of brivaracetam and lacosamide on human glioma cells (Q33768138) (← links)
• Therapeutic control and resistance of the EGFR-driven signaling network in glioblastoma (Q35341639) (← links)
• Microglia Activate Migration of Glioma Cells through a Pyk2 Intracellular Pathway (Q35670813) (← links)
• A wide spectrum of EGFR mutations in glioblastoma is detected by a single clinical oncology targeted next-generation sequencing panel (Q35963284) (← links)
• Epidermal growth factor receptor targeting and challenges in glioblastoma (Q36977684) (← links)
• Inhibition of glioblastoma cell proliferation, migration and invasion by the proteasome antagonist carfilzomib. (Q38776733) (← links)
• Inhibition of cell proliferation, migration and invasion by a glioma-targeted fusion protein combining the p53 C terminus and MDM2-binding domain (Q38796979) (← links)
• EGFR as a Target for Glioblastoma Treatment: An Unfulfilled Promise. (Q40089704) (← links)
• Protein residues that control the reaction trajectory in S-adenosylmethionine radical enzymes: mutagenesis of asparagine 153 and aspartate 155 in Escherichia coli biotin synthase (Q40235325) (← links)
• Epidermal growth factor receptor activity is elevated in glioma cancer stem cells and is required to maintain chemotherapy and radiation resistance (Q42700778) (← links)
• 3D Mathematical Modeling of Glioblastoma Suggests That Transdifferentiated Vascular Endothelial Cells Mediate Resistance to Current Standard-of-Care Therapy. (Q46025187) (← links)
• COX-2/sEH dual inhibitor PTUPB suppresses glioblastoma growth by targeting epidermal growth factor receptor and hyaluronan mediated motility receptor (Q46353205) (← links)
• Spatially graded hydrogels for preclinical testing of glioblastoma anticancer therapeutics. (Q47259620) (← links)
• Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies (Q50100856) (← links)
• Connexin 43 C-terminus directly inhibits the hyperphosphorylation of Akt/ERK through protein-protein interactions in glioblastoma (Q58792718) (← links)
• Effect of Compound Kushen Injection, a Natural Compound Mixture, and Its Identified Chemical Components on Migration and Invasion of Colon, Brain, and Breast Cancer Cell Lines (Q64085227) (← links)
• Spectrum of EGFR aberrations and potential clinical implications: insights from integrative pan-cancer analysis (Q89750470) (← links)
• The Role of Rho GTPases in Motility and Invasion of Glioblastoma Cells (Q89849496) (← links)
• Practical Bioinformatic DNA-Sequencing Pipeline for Detecting Oncogene Amplification and EGFRvIII Mutational Status in Clinical Glioblastoma Samples (Q89995854) (← links)
• The Bradykinin-BDKRB1 Axis Regulates Aquaporin 4 Gene Expression and Consequential Migration and Invasion of Malignant Glioblastoma Cells via a Ca2 -MEK1-ERK1/2-NF-κB Mechanism (Q90396131) (← links)
• Screening of Methylation Signature and Gene Functions Associated With the Subtypes of Isocitrate Dehydrogenase-Mutation Gliomas (Q91712028) (← links)